Beijing has unveiled the "AI + Medical and Health Innovation Development Action Plan," aimed at leveraging national laboratories and other innovative entities to delve into the fundamental theories and algorithms of AI within the realm of life sciences. The plan emphasizes breaking new ground in uncovering the essence of life and pathogenic mechanisms. It will prioritize advancements in technologies such as virtual cells, medical digital twins, and DNA storage, while fostering the integration of cutting-edge cognitive and brain-inspired intelligence technologies into the medical and healthcare sectors. Additionally, the plan supports the research and development of independently controllable, multi-scale biomedical models to enhance the efficiency and success rates of target discovery and clinical trials.